Sugi Predict

Sugi Predict / Compounds / SCHEMBL264277

SCHEMBL264277

SCHEMBL264277

[O-]/[N+](=C/c1ccccc1)c1ccccc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.73
▸ MAPT P10636 8/20 0.73
▸ G6PD P11413 3/20 0.73
▸ ALOX15 P16050 2/20 0.73
▸ TSHR P16473 1/20 0.73
▸ RECQL P46063 1/20 0.73
▸ NPC1 O15118 5/20 0.59
▸ RAB9A P51151 4/20 0.59
▸ HSD17B10 Q99714 2/20 0.47
▸ HPGD P15428 1/20 0.47
▸ MAPK1 P28482 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ POLB P06746 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ LMNA P02545 1/20 0.44
▸ NFE2L2 Q16236 1/20 0.44
▸ FBP1 P09467 2/20 0.42
▸ TDP1 Q9NUW8 1/20 0.40
▸ MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL264278 1.00 ALDH1A1 (0.73) ALDH1A1MAPTG6PDALOX15TSHR
SCHEMBL12349218 1.00 ALDH1A1 (0.73) ALDH1A1MAPTG6PDALOX15TSHR
SCHEMBL19875637 0.95 ALDH1A1 (0.80) ALDH1A1MAPTG6PDALOX15TSHR
SCHEMBL16634847 0.89 ALDH1A1 (0.76) ALDH1A1MAPTG6PDALOX15TSHR
SCHEMBL16634831 0.89 ALDH1A1 (0.76) ALDH1A1MAPTG6PDALOX15TSHR
SCHEMBL11405083 0.85 G6PD (0.67) ALDH1A1MAPTG6PDALOX15TSHR
SCHEMBL11406588 0.85 ALDH1A1 (1.00) ALDH1A1MAPTG6PDALOX15TSHR
SCHEMBL2248023 0.85 G6PD (0.67) ALDH1A1MAPTG6PDALOX15TSHR
SCHEMBL12355268 0.85 G6PD (1.00) ALDH1A1MAPTG6PDALOX15TSHR
SCHEMBL11408998 0.85 G6PD (0.67) ALDH1A1MAPTG6PDALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1655070-B1 OXIDATION CATALYST ASAHI KASEI CHEMICALS CORP (JP) 2015-07-15 — — EP disclosed
WO-2014004784-A1 GENERATION OF HEPATOCYTES FROM PLURIPOTENT STEM CELLS ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) 2014-01-03 — — WO disclosed
US-8133834-B2 Oxidation catalyst ASAHI KASEI CHEMICALS CORPORATION (JP) 2012-03-13 — — US disclosed
US-20110201661-A1 Spiro Derivatives of Parthenin as Novel Anticancer Agents COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2011-08-18 — — US disclosed
US-20100069670-A1 Oxidation catalyst ASAHI KASEI CHEMICALS CORPORATION (JP) 2010-03-18 — — US disclosed
US-20090093641-A1 Synthesis of Pentafluorosulfanyl (SF5)-Substituted Heterocycles and Alkynes UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2009-04-09 — — US disclosed
US-20060229471-A1 Oxidation catalyst ASAHI KASEI CHEMICALS CORPORATION (JP) 2006-10-12 — — US disclosed
EP-1655070-A1 OXIDATION CATALYST Asahi Kasei Chemicals Corporation (JP) 2006-05-10 — — EP disclosed
US-20050272724-A1 Spin trapping pharmaceutical compositions and methods for use thereof CARNEY JOHN M 2005-12-08 — — US disclosed
US-20050107366-A1 Spin trapping pharmaceutical compositions and methods for use thereof CARNEY JOHN M (US) 2005-05-19 — — US disclosed
EP-0590072-A1 USE OF SPIN TRAPPING FOR THE TREATMENT OF DISEASES ASSOCIATED WITH OXIDATION OF LIPIDS AND PROTEINS Oklahoma Medical Research Foundation (US) 1994-04-06 — — EP disclosed
WO-1992022290-A1 USE OF SPIN TRAPPING FOR THE TREATMENT OF DISEASES ASSOCIATED WITH OXIDATION OF LIPIDS AND PROTEINS OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) 1992-12-23 — — WO disclosed
US-4224340-A Anti-inflammatory compositions containing α-phenyl-N-phenylnitrone compounds WILLIAM H. RORER, INC. (US) 1980-09-23 — — US disclosed
US-4224340-A Anti-inflammatory compositions containing α-phenyl-N-phenylnitrone compounds WILLIAM H. RORER, INC. (US) 1980-09-23 — — US disclosed
US-4214003-A ANTIINFLAMMATORY AGENTS WILLIAM H. RORER, INC. (US) 1980-07-22 — — US disclosed
US-4214003-A ANTIINFLAMMATORY AGENTS WILLIAM H. RORER, INC. (US) 1980-07-22 — — US disclosed
US-4197314-A WITH A DIPHENYL NITRONE WILLIAM H. RORER, INC. (US) 1980-04-08 — — US disclosed
US-4197314-A WITH A DIPHENYL NITRONE WILLIAM H. RORER, INC. (US) 1980-04-08 — — US disclosed
US-4153722-A ANTIINFLAMMATORY, A-PHENYL-N-PHENYLNITRONE WILLIAM H. RORER, INC. (US) 1979-05-08 — — US disclosed
US-4153722-A ANTIINFLAMMATORY, A-PHENYL-N-PHENYLNITRONE WILLIAM H. RORER, INC. (US) 1979-05-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050272724-A1 Spin trapping pharmaceutical compositions and methods for use thereof PPOX, TXN2, TXN ALDH1A1 2407/4885MAPT 697/4885G6PD 651/4885
US-20110201661-A1 Spiro Derivatives of Parthenin as Novel Anticancer Agents CDK10, NEK10, AKR1B10 ALDH1A1 1855/4885MAPT 4489/4885G6PD 3468/4885
US-20090093641-A1 Synthesis of Pentafluorosulfanyl (SF5)-Substituted Heterocycles and Alkynes SF3B5, SF1, SF3B3 ALDH1A1 1538/4885MAPT 4525/4885G6PD 1762/4885
US-20100069670-A1 Oxidation catalyst PPOX, SOD1, HAO2 ALDH1A1 377/4885MAPT 3864/4885G6PD 198/4885
US-20050107366-A1 Spin trapping pharmaceutical compositions and methods for use thereof PPOX, TXN2, TXN ALDH1A1 2407/4885MAPT 697/4885G6PD 651/4885
US-20060229471-A1 Oxidation catalyst PPOX, SOD1, HAO2 ALDH1A1 377/4885MAPT 3864/4885G6PD 198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.